The pathology of large-vessel vasculitides

被引:0
作者
Miller, D. V. [1 ]
Maleszewski, J. J. [2 ]
机构
[1] Univ Utah, Dept Pathol, Intermt Cent Lab, Salt Lake City, UT USA
[2] Mayo Clin, Div Anat Pathol, Rochester, MN USA
关键词
aortitis; giant cell arteritis; Takayasu; IgG4; GIANT-CELL ARTERITIS; ASCENDING AORTIC-ANEURYSM; RETROPERITONEAL FIBROSIS; SURGICAL PATHOLOGY; DISSECTION; REGURGITATION; DISEASE; PERIAORTITIS; PROPOSAL; LESION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasculitis affecting large elastic arteries, including the aorta and major proximal branches, encompasses various diseases including Takayasu arteritis, giant cell (or temporal) arteritis, and tertiary syphilis, but also may occur as a rare complication of Behcet's disease, rheumatoid arthritis sarcoidosis, Cogan syndrome, Kawasaki disease, ankylosing spondylitis, systemic lupus erythematosus and Wegener's granulomatosis. Recent reports have also established a link between inflammatory abdominal aortic aneurysm as well as lymphoplasmacytic thoracic aortitis with an overabundance of IgG4-producing plasma cells and the burgeoning constellation of "Hyper-IgG4" syndromes. This review focuses on morphologic aspects of large-vessel vasculitis pathology associated with giant cell arteritis, Takayasu arteritis, idiopathic or isolated aortitis, lymphoplasmacytic thoracic and ascending aortitis, and the inflammatory aneurysm/retroperitoneal fibrosis syndrome.
引用
收藏
页码:S92 / S98
页数:7
相关论文
共 50 条
  • [1] Diagnosis and differential diagnosis of large-vessel vasculitides
    Gokhan Keser
    Kenan Aksu
    Rheumatology International, 2019, 39 : 169 - 185
  • [2] Diagnosis and differential diagnosis of large-vessel vasculitides
    Keser, Gokhan
    Aksu, Kenan
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (02) : 169 - 185
  • [3] Biologic treatment of large-vessel vasculitides
    Schaefer, Valentin S.
    Zwerina, Jochen
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (01) : 31 - 37
  • [4] Morbidity and Mortality of Large-Vessel Vasculitides
    Matthew J. Koster
    Kenneth J. Warrington
    Eric L. Matteson
    Current Rheumatology Reports, 2020, 22
  • [5] Morbidity and Mortality of Large-Vessel Vasculitides
    Koster, Matthew J.
    Warrington, Kenneth J.
    Matteson, Eric L.
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (12)
  • [6] Magnetic resonance imaging and magnetic resonance angiography in large-vessel vasculitides
    Guggenberger, K. V.
    Bley, T. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : S103 - S107
  • [7] Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
    David Carmona, F.
    Coit, Patrick
    Saruhan-Direskeneli, Guher
    Hernandez-Rodriguez, Jose
    Cid, Maria C.
    Solans, Roser
    Castaneda, Santos
    Vaglio, Augusto
    Direskeneli, Haner
    Merkel, Peter A.
    Boiardi, Luigi
    Salvarani, Carlo
    Gonzalez-Gay, Miguel A.
    Martin, Javier
    Sawalha, Amr H.
    SCIENTIFIC REPORTS, 2017, 7
  • [8] Recommendations of the European League Against Rheumatism (EULAR) in the treatment of "large-vessel vasculitides"
    Wipfler-Freissmuth, E.
    Moosig, F.
    Schirmer, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (03): : 260 - +
  • [9] Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics
    Xu, Shuang
    Jiemy, William F.
    Brouwer, Elisabeth
    Burgess, Janette K.
    Heeringa, Peter
    van der Geest, Kornelis S. M.
    Alba-Rovira, Roser
    Corbera-Bellalta, Marc
    Boots, Annemieke H.
    Cid, Maria C.
    Sandovici, Maria
    AUTOIMMUNITY REVIEWS, 2024, 23 (06)
  • [10] Management of large-vessel vasculitis
    Salvarani, Carlo
    Hatemi, Gulen
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (01) : 25 - 31